France Lifts Clinical Hold From AB Science’s Masitinib

 
• By Scrip Team

After two years on clinical hold, the French biotech has resolved quality and pharmacovigilance problems that forced it to suspend studies of masitinib, moving it a step closer to restarting trials in its home country.

Birdcage
AB Free To Start trials in France after clinical hold • Source: Shutterstock

More from Clinical Trials

More from R&D